These effects, along with a previous report showing that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like behavior in mice,2 assist the strategy of targeting ACKR3 as a singular technique to modulate the opioid program, which could open new therapeutic avenues for opioid-relevant Conditions. Gene expression Evaluation revealed that ACKR3 https://carolez691xup9.blogthisbiz.com/profile